We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cdc Corp. (MM) | NASDAQ:CHIND | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.22 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September 17, 2010
Commission File Number: 000-30134
CDC CORPORATION
(Translation of Registrants name into English)
Cayman Islands
(Jurisdiction of incorporation or organization)
11/F, ING Tower
308 Des Voeux Road Central
Hong Kong
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: x Form 20-F ¨ Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: ¨ Yes x No
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): n/a
Other Events.
Mr. Stephen Dexter has transitioned from his role as Chief Accounting Officer of CDC Software Corporation (CDC Software) and has been appointed Chief Financial Officer of CDC Software. Mr. Dexter also remains as Chief Accounting Officer of CDC Corporation (the Company). Mr. Matthew Lavelle remains as Chief Financial Officer of the Company.
Exhibit |
Description |
|
1.01 |
Press release dated September 1, 2010 CDC Corporation Files Opposition to Evolutions Preliminary Injunction Motion |
|
1.02 |
Press release dated September 1, 2010 CDC Corporation to Initiate New Share Repurchase Program |
|
1.03 |
Press release dated September 13, 2010 CDC Corporation to Receive $6.5 Million Dividend from China.com Portfolio Company |
|
1.04 |
Press release dated September 14, 2010 CDC Corporation to Launch a Private Equity RMB Fund with the China Government |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: September 17, 2010
CDC CORPORATION | ||
By: |
/s/ Donald L. Novajosky |
|
Name: | Donald L. Novajosky | |
Title: | Vice President and Associate General Counsel |
EXHIBIT INDEX
Exhibit |
Description |
|
1.01 |
Press release dated September 1, 2010 CDC Corporation Files Opposition to Evolutions Preliminary Injunction Motion |
|
1.02 |
Press release dated September 1, 2010 CDC Corporation to Initiate New Share Repurchase Program |
|
1.03 |
Press release dated September 13, 2010 CDC Corporation to Receive $6.5 Million Dividend from China.com Portfolio Company |
|
1.04 |
Press release dated September 14, 2010 CDC Corporation to Launch a Private Equity RMB Fund with the China Government |
1 Year Cdc Corp. (MM) Chart |
1 Month Cdc Corp. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions